Non-invasive analysis of genomic copy number variation in patients with hepatocellular carcinoma by next generation DNA sequencing

Journal of Cancer

Volumn 6, Issue 3, 2015, Pages 247-253

  Xu, Hongtao ^a   Zhu, Xia ^b   Xu, Zulong ^a   Hu, Yue ^b   Bo, Shiping ^b   Xing, Tongjing ^a   Zhu, Kuichun ^b  

^a Taizhou People's Hospital   (China)

^b TQB Building   (China)

Author keywords

DNA sequencing; Genomic copy number variation; HCC

Indexed keywords

ALPHA FETOPROTEIN; CELL FREE DNA; DNA; UNCLASSIFIED DRUG;

ADULT; AGED; ALPHA FETOPROTEIN BLOOD LEVEL; ARTICLE; CANCER SIZE; CENTROMERE; CHROMOSOME 14Q; CHROMOSOME 17Q; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME 1Q; CHROMOSOME 22Q; CHROMOSOME 4Q; CHROMOSOME 7Q; CHROMOSOME 9Q; CHROMOSOME ARM; CHROMOSOME LOSS; CHRONIC HEPATITIS; CLINICAL ARTICLE; COPY NUMBER VARIATION; COPY NUMBER VARIATION Z SCORE ANALYSIS; DIFFERENTIAL DIAGNOSIS; DNA SEQUENCE; EARLY DIAGNOSIS; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NEXT GENERATION SEQUENCING; NON INVASIVE MEASUREMENT; SCORING SYSTEM; TELOMERE; VERY ELDERLY;

EID: 84923647126     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.10747     Document Type: Article

References (15)

1. Lim KC, Chow PK, Allen JC, et al. Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria. Br J Surg. 2012; 99(12): 1622-1629.
2. Gullapalli RR, Lyons-Weiler M, Petrosko P, et al. Clinical integration of next-generation sequencing technology. Clin Lab Med. 2012; 32(4): 585-599.
3. Ong FS, Lin JC, Das K, et al. Translational utility of next-generation sequencing. Genomics. 2013; 102(3): 137-139.
4. Ulahannan D, Kovac MB, Mulholland PJ, et al. Technical and implementation issues in using next-generation sequencing of cancers in clinical practice. Br J Cancer. 2013; 109(4): 827-835.
5. Leary RJ, Sausen M, Kinde I, et al. Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing. Sci Transl Med. 2012; 4(162): 162ra154.
6. Forshew T, Murtaza M, Parkinson C, et al. Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Sci Transl Med. 2012; 4(136): 136ra68.
7. Shaw JA, Page K, Blighe K, et al. Genomic analysis of circulating cell-free DNA infers breast cancer dormancy. Genome Res. 2012; 22(2): 220-231.
8. Murtaza M, Dawson SJ, Tsui DW, et al. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature. 2013; 497(7447): 108-112.
9. Chan KC, Jiang P, Chan CW, et al. Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing. Proc Natl Acad Sci U S A. 2013; 110(47): 18761-18768.
10. Guan XY, Fang Y, Sham JS, et al. Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes Cancer. 2000; 29(2): 110-116.
11. Zondervan PE, Wink J, Alers JC, et al. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias. J Pathol. 2000; 192(2): 207-215.
12. Wang G, Zhao Y, Liu X, et al. Allelic loss and gain, but not genomic instability, as the major somatic mutation in primary hepatocellular carcinoma. Genes Chromosome Cancer. 2001; 31(3): 221-227.
13. Furge KA, Dykema KJ, Ho C, et al. Comparison of array-based comparative genomic hybridization with gene expression-based regional expression biases to identify genetic abnormalities in hepatocellular carcinoma. BMC Genomics. 2005; 6: 67.
14. Zhu L, Hu Y, Wang J, Zhu X, et al. Screening for gene mutations in hypertrophic cardiomyopathy by targeted exon amplification and next generation DNA sequencing: a pilot study with three Chinese families. Exp Clin Cardiol. 2014; 20(8): 4340-4354.
15. Xing TJ, Xu HT, Yu WQ, et al. Methylation regulation of liver-specific microRNA- 122 expression and its effects on the proliferation and apoptosis of hepatocellular carcinoma cells. Genet Mol Res. 2013; 12(3): 3588-3597.